group A is lactoferrin group, receiving 100mg sachet of lactoferrin once daily.

group B is the ferrous sulfate group, receiving 6mg/kg/ day single dose of ferrous sulfate.

Anemia, Iron Deficiency

Lactoferrin

Ferrous Sulfate

Primary care center

Lactoferrin for Treatment of Iron Deficiency Anemia.

Comparison of Lactoferrin vs Traditional Iron Therapy for Treatment of Iron Deficiency Anemia in School-age Children.

Saeed Salah Abduljalil Soliman

Lecturer of family medicine

Cairo University

the population for the study will be Scholar age Children attend family medicine clinic for treatment of iron deficiency anemia and their parents accept participation in the study.
For confirmation of the diagnosis of iron deficiency anemia the following investigations will be done:
CBC
Serum total iron
full medical history and examination will be performed. study participants will be assigned to either group A (lactoferrin group) or group B (ferrous sulfate group), and will receive the corresponding medication for 8 weeks.
4 weeks follow up for side effects and hemoglobin level and 8 weeks follow up for side effects, hemoglobin level and serum iron will be performed.

Chronic Diarrhea

Moustafa Abd Ellatif

Epidemiology of Chronic Diarrhea Among Children Admitted to Gastroenterology Unit at Assuit University Children Hospital

Not yet recruiting: Participants are not yet being recruited

moustafa abd ellatif

director clinical research

Assiut University

We will recruit 10 healthy adult volunteers, over 18 years of age, who eat at least three servings of fish per week (since this diet is associated with detectable levels of mercury in the urine which may rise following chelation). Patients with known allergies to DMPS or sulfa drugs or history of neurologic or renal disease will be excluded. We will also control for number of mercury containing dental amalgams. History will be obtained regarding any potential mercury exposures or recent vaccinations.

Toxicity

12 hr urine mercury and creatinine levels will be measured on all volunteers prior to any treatment. The urine will be collected in acid-washed or heavy-metal-free specialty containers. Each volunteer will then receive 120 mg of transdermal DMPS, applied to the bicep area of one arm. The area of application will not exceed 2% body surface area. After dosing, urine will be collected for the next 12 hours (using the same protocol and send-out procedure) and assayed for mercury and creatinine levels.
Additionally, after dosing, an intravenous catheter will be placed in the arm of each subject for blood draws. Blood samples will be obtained at 30 minutes, 60 minutes, 90 minutes, 2 hours, 4 hours and 6 hours after application of the DMPS.

transdermal DMPS

Department of Medical Toxicology

Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion

Transdermal Absorption of DMPS and Its Effect on Urinary Mercury Excretion

Anne-Michelle Ruha, M.D.

Banner Health

Phoenix Children's Hospital

Study treatment will consist of BCP, three 1.2 g oral tablets (equivalent to 600 mg of BCP each) for 4 weeks, from cows immunized to insulin. Patients will be followed for safety monitoring for an additional 4 weeks.

salmonella infections/pahoinvointi

Lactoferrin for Treatment of Iron Deficiency Anemia.

Epidemiology of Chronic Diarrhea Among Children Admitted to Gastroenterology Unit at Assuit University Children Hospital

Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion

Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease

Täydellisin lääketieteellinen tietokanta tieteen tukemana